IMPLICATIONS FOR REHABILITATION 1
• Patients undergoing lower limb amputation face major physical and psychological challenges 2 after surgery that have a considerable impact on rehabilitation and their ability to walk 3 independently. 4
• Many amputees are unable able to walk with a prosthetic limb, but there are no validated 5 tools to predict this before surgery. 6
• The BLARt is a potentially valuable measure that can predict the likelihood of being unable 7 to walk after amputation. 8
• It is simple to use and could be useful to inform patients' and clinicians' expectations before 9 surgery 10 11 12 13 INTRODUCTION 1 Recent estimates suggest that approximately 5000 people in the UK and 50,000 in the USA 2 undergo major lower limb amputation each year. 1, 2 It is difficult to quantify precise numbers 3 worldwide because many countries do not keep accurate data. Most lower limb 4 amputations (80%) are performed for peripheral vascular disease; 40% of these are 5 performed in diabetics. 3 Other common indications are trauma, malignancy, congenital 6 deformities and in extreme cases, chronic pain. 7 Major lower limb amputation has a huge impact on a patient's physical capabilities, quality 8 of life and requires many adjustments to daily life. 4 The importance of being able to 9 estimate an individual's potential to walk with a prosthesis after amputation has been 10 recognised. 5 Effective rehabilitation to achieve independent walking with a prosthetic limb 11 is physically and mentally challenging. The ability to walk independently with a prosthesis is 12 determined by several factors, including patient age, physical fitness, the presence of 13 associated injuries or co-morbidities, patient motivation, social circumstances and the 14 availability of support. 6 The reliability, comfort, ease of use and functionality of the 15 prosthesis are also important. 2 
16
Accurate and informed information should be at the heart of decision-making before 17 amputation. 7 However, it is difficult to predict before surgery whether a patient will be able 18 to walk independently after lower limb amputation . 5, 8 Several pre-operative 9-12 and post-19 operative factors [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] have been associated with the likelihood of being able to walk with a 20 prosthetic limb, but there are no validated methods of predicting this before amputation 21 surgery . 22 Best practice should ensure that patients are informed in detail before surgery about what 1 type of prosthesis may be suitable, and that they are counselled about their likely 2 prognosis. 23 This can help manage expectations as well as plan for environmental changes at 3 home or at work, returning to driving and attending social activities. 6 However, these 4 discussions do not always occur, partly because of the urgent nature of many lower limb 5 amputations. 7 When pre-amputation discussions do occur there is evidence that patients' 6 expectations of being able to walk independently with a prosthetic limb are often unrealistic 7 24 and this is borne out by our own clinical experience. This may relate to the prominent 8 media profile of some amputees including war veterans and disabled athletes. Alternatively, 9 advice from surgeons that patients will be suitable for prosthetic rehabilitation after 10 amputation may be over-optimistic, based on a lack of knowledge or available evidence in 11 predicting longer term outcome in different patient groups, or a reluctance to emphasise 12 negative outcomes before surgery. 13 Therefore the aims of this study were to identify pre-operative factors associated with the 14 ability to walk with a prosthetic limb after major lower limb amputation. These would 15 inform the development of a predictive assessment tool that could be used to predict the 16 likelihood of walking with a prosthesis after surgery. 
METHODS

2
We conducted a service review of mobility outcomes of all patients (n=350) referred for The use of anonymised patient information was approved by the institutional review board 9 and individual patient consent was not required Functional outcome was determined using 10 the NHS prosthetic activity coding classification in use at the time (A0L-non limb user, A1L-11 limited household/cosmetic user, A2L -limited community/household user, A3L -active 12 adult, A4L -very active adult or athlete). 25 3 Of 350 patients included in the creation dataset, functional outcome data was not recorded 4 for 12 patients so data from 338 patients were analysed ( Table 2 ). The characteristics of the 5 patient groups are indicated in Tables 2 and 3 . Mortality at 12 months was 18.6%. Factors independently associated with a poor functional outcome (AOL or A1L) on univariate 8 analysis were trans-femoral amputation, age > 70 years, male sex, vascular aetiology, renal 9 failure requiring dialysis, diabetes and prior stroke (Table 4 ) and these were entered into the 10 multinomial analysis.
RESULTS
2
Creation dataset
11
Insert table 4 about here.
12
Ischaemic heart disease, obesity, respiratory disease, contralateral limb problems, cognitive 13 dysfunction were not associated with mobility outcome but absolute numbers of patients 14 with these pathologies were low. On multinomial analysis, age, sex, trans-femoral 15 amputation, vascular aetiology and renal failure were independent predictors of non-16 functional mobility outcome (Table 5) .
17
Insert The BLARt scoring system (Table 1) No patient with a BLARt score ≥13 was able to walk independently with a prosthesis (SIGAM 13 E or F) and only 6 patients with a BLARt score ≥17 were able to walk independently with a 14 prosthesis for any distance (SIGAM C or greater). The overall sensitivity of the BLARt score 15 for predicting poor functional outcome (SIGAM D or below) was 95.5% and the specificity 16 was 77.2%; positive and negative predictive values were 97.2% and 45.5% respectively.
Using a threshold of BLARt score ≥13 or less gave 100% sensitivity and 66.7% specificity for In this study we found that patients with a BLARt score of ≥ 13 did not achieve a good 3 functional outcome (SIGAM grade E or F) following lower limb amputation and those with a 4 score of ≥17 did not achieve any walking function (SIGAM grade C or greater). The BLARt 5 assessment was highly sensitive in identifying a patient's subsequent ability to walk. Hence the utility of the BLARt is to predict those patients who are unlikely to rehabilitate 21 successfully rather than those who will.
22
Implications for practice 1 The BLARt score is a relatively simple tool that will allow risk stratification for the purposes Limitations of the current study 2 The creation dataset comprised routine collected data which did not include variables such 3 as categorised body mass index, pre-amputation mobility levels and classification of 4 cognitive impairment. Hip disarticulation, and bilateral amputations were also not classified 5 separately. However, the study team considered these to be vital factors which affect the 6 success of rehabilitation and therefore, following consensus decision, they were included 7 and weighted in the formulation of the BLARt score. There were very few through-knee 8 amputations in our datasets and so these have been grouped together with the 9 transfemoral group. We feel this is logical as in our experience the absence of a knee joint 10 (as in transfemoral or through knee amputations) is a major limiting factor in rehabilitation 11 The incidence of diabetes was included in the creation dataset analysis and was a significant 12 co morbidity (n=152, 45% of patients undergoing amputation). However, we omitted 13 diabetes from the BLARt assessment because whilst it is an underlying risk factor for 14 peripheral vascular disease and amputation it does not necessarily impact on rehabilitation.
15
In attempting to distinguish between patients with unlimited walking distance before 16 surgery and those able to walk a limited distance unaided, we used ability to walk 3 miles as 17 a surrogate for unlimited walking, which approximates to a SIGAM mobility grade F 18 (normal/near normal walking) and NHS prosthetic activity code A3L. We realise that this 19 definition is to some extent subjective, but our intention was to predict broadly whether a 20 patient would achieve any walking function (SIGAM grade C or greater) or independent 21 mobility (SIGAM grade E or F). To achieve this it is more important to distinguish levels of 22 immobility rather of extended mobility before surgery. It is possible that a different 23 definition of unlimited or normal walking might have improved performance of the BLARt, 1 but we believe this is unlikely, and grouped SIGAM grades E and F together for analysis. 2 We recognise that there are several other post-operative factors that can impact on the 3 success of prosthetic ambulation and good functional outcome. Wound healing, stump 4 characteristics (affecting prosthetic fitting), phantom limb pain, amputation stump pain and 5 psychosocial issues 37, 46, 47 can all prolong the rehabilitation process. However these cannot 6 be predicted before surgery and therefore are not accounted for in the BLARt assessment. 
3
Score 3 -Toe / partial foot amputation (difficulty weight bearing due to neuropathy or balance issues).
4
Score 4 -Previous amputation or severe disease to limb (not able to weight bear or stand).
6
2 Severe Respiratory Disease -defined as a history of COPD, home oxygen therapy or shortness of breath at rest. 
21
Score 3 -Limited Carry Over (able to understand but not retain information).
22
Score 0 -Alert/ Aware (able to understand and retain information). 
